Genmab A/s
(OTC) GNMSF
Genmab A/s Financials at a Glance
Market Cap
$16.87BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$3.89B
Net Income (TTM)
$820.26M
EPS (TTM)
$13.21
P/E Ratio
21.25
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Price
$275.79
Volume
355
Open
$282.75
Price
$275.79
Volume
355
Open
$282.75
Previous Close
$275.79
Daily Range
$275.79 - $282.75
52-Week Range
$208.80 - $352.00
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.35 (Low)
Price
$275.79
Volume
355
Open
$282.75
Previous Close
$275.79
Daily Range
$275.79 - $282.75
52-Week Range
$208.80 - $352.00
Estimated Earnings Date
Aug 6, 2026
GNMSF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genmab A/s
Industry
Biotechnology
Sector
Health CareEmployees
3,088
CEO
Jan G. J. van de Winkel, PhD
Website
www.genmab.comHeadquarters
Copenhagen, CD 1560, DK
GNMSF Financials
Key Financial Metrics (TTM)
Gross Margin
38.65%
Operating Margin
13.67%
Net Income Margin
8.73%
Return on Equity
14.53%
Return on Capital
11.39%
Return on Assets
6.63%
Earnings Yield
4.71%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.87BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
59.49M
Volume
355
Avg. Volume
2.19K
Financials (TTM)
Gross Profit
$3.63B
Operating Income
$1.28B
EBITDA
$1.41B
Operating Cash Flow
$903.38M
Capital Expenditure
-$30.13M
Free Cash Flow
$873.25M
Cash & ST Invst.
$1.52B
Total Debt
$5.35B
Genmab A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$882.27M
+18.3%
Gross Profit
$818.26M
+16.5%
Gross Margin
92.75%
N/A
Market Cap
$16.87BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$6.39M
N/A
Employees
2,638
N/A
Net Income
$52.19M
-73.2%
EBITDA
$215.00M
-18.9%
Quarterly Fundamentals
Total Cash
$1.52B
-53.6%
Total Debt
$5.35B
+3581.3%
Accounts Receivable
$1.03B
+26.9%
Inventory
$21.00M
+72.2%
Long Term Debt
$5.06B
+3757.4%
Short Term Debt
$293.01M
+1958.9%
Return on Assets
6.63%
N/A
Return on Invested Capital
11.49%
N/A
Free Cash Flow
-$1.97M
-100.8%
Operating Cash Flow
$2.95M
-99.0%